Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae502Source: DataRank Database

Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: greenTopics (27)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (94)

Yuwei Zhu ORCID,Ine Sohn,William B. Stubblefield ORCID,Michael B. Streiff ORCID,Manjusha Gaglani ORCID

Live enrichment

PubMed:39405261 PMC:PMC12063076 OpenAlex:https://openalex.org/W4403423130

United States Centers for Disease Control and Prevention

Grant: 75D30119C05670

United States Centers for Disease Control and Prevention

Grant: 75D30120C07637

United States Centers for Disease Control and Prevention

Grant: 75D30120F00002

United States Centers for Disease Control and Prevention

Grant: 75D30122C12914

NIGMS NIH HHS

Grant: R35 GM151147

NHLBI NIH HHS

Grant: T32 HL087738

NIH

FWCI

0.00

Citation Percentile

0.3%

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12063076/pdf/jiae502.pdf

publisherhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae502/60412456/jiae502.pdf

publisherhttps://academic.oup.com/jid/article-pdf/231/2/378/60412456/jiae502.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12063076

Fields of Study

Heparin-Induced Thrombocytopenia and ThrombosisSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesVaccine EfficacyAgedFemaleHospitalizationHumansMaleMiddle AgedVaccinationVenous Thromboembolism

Keywords

Interquartile rangeMedicineVaccinationCoronavirus disease 2019 (COVID-19)Confidence intervalInternal medicineImmunologyDiseaseVaccineVenous ThromboembolismCovid-19Sars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being